Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,092
in 3 filings, $19K under 10b5-1 plans

Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$16K CEO sold 2% of stake
  2. Burkly Linda −$2K EVP, CHIEF SCIENTIFIC OFFICER sold 1% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-07 Albright Charles Chief Scientific Officer Sale −622 $26.95 $17K 31,524
2020-02-06 Albright Charles Chief Scientific Officer Grant or award +11,593 32,146
2020-02-06 Albright Charles Chief Scientific Officer Grant or award · Stock Option (right to buy) +69,556 69,556
2020-02-06 Collins Cynthia CEO Grant or award +15,625 46,998
2020-02-06 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +93,750 93,750
2020-02-03 Albright Charles Chief Scientific Officer Sale −5,549 $26.54 $147K 20,553
2020-01-31 Albright Charles Chief Scientific Officer Option exercise +17,977 26,102
2020-01-31 Albright Charles Chief Scientific Officer Option exercise · Restricted Stock Units −17,977 0
2020-01-09 ROBERTSON MICHELLE Chief Financial Officer Grant or award +20,000 20,000
2020-01-09 ROBERTSON MICHELLE Chief Financial Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2019-10-28 Abrams Judith R Chief Medical Officer Grant or award +25,000 25,000
2019-10-28 Abrams Judith R Chief Medical Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2019-09-11 Collins Cynthia CEO Grant or award +20,000 31,373
2019-09-11 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +500,000 500,000
2019-09-11 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2019-08-19 Collins Cynthia CEO Grant or award +8,283 16,566
2019-08-19 Collins Cynthia CEO Sale −5,193 $25.83 $134K 11,373
2019-08-06 Collins Cynthia CEO Grant or award +8,283 16,566
2019-06-12 Hirsch Andrew Director Grant or award · Stock Option (right to buy) +11,538 11,538
2019-06-12 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538

Page 12 of 15 · 283 trades